Maravai LifeSciences Expands Oligonucleotide Business, Leases New Facility for TriLink BioTechnologies

Maravai LifeSciences, a leader in providing reagents to researchers, biotherapeutics manufacturers and OEM partners worldwide, today announced plans to relocate and expand its TriLink BioTechnologies operations with the signing of a lease on a new facility in the Sorrento Valley area of San Diego. TriLink will consolidate its San Diego facilities into a new 95,000-square-foot space with an option to expand for future growth.

Read More
walter Lentfert
Maravai LifeSciences Expands Top Management Team with Four New Hires

SAN DIEGO, Calif. (May 1, 2018) – Maravai LifeSciences, a leader in providing reagents to researchers, biotherapeutics manufacturers and OEM partners worldwide, today announced the addition of four senior management executives. The new hires have assumed key positions in two of Maravai LifeSciences operating businesses: TriLink BioTechnologies and Cygnus Technologies.

Read More
David Weber
Maravai LifeSciences and GTCR Complete Acquisition of Solulink Commercial Assets

SAN DIEGO, CA (December 27, 2016) Maravai LifeSciences (“Maravai”), a leader in providing specialty reagents to life sciences researchers, biotherapeutics manufacturers and OEM partners worldwide, today announced it has completed the acquisition of the commercial assets of Solulink Incorporated (“Solulink”).  The Solulink assets will be part of the product portfolio offered by Maravai’s TriLink BioTechnologies (“TriLink”) subsidiary.

Read More
walter Lentfert